Alloprevotella is a genus of Gram-negative, rod-shaped, non-spore-forming bacteria within the Bacteroidetes phylum and Prevotellaceae family.
Alloprevotella species are a normal part of the human microbiome, predominantly colonizing the oral cavity and digestive tract. They are commonly associated with plant-rich diets high in carbohydrates and fibers, contributing to microbial stability.
While some strains of Alloprevotella are linked to health benefits like improved cardiovascular health and glucose metabolism, others have been implicated in inflammatory diseases such as metabolic syndrome, obesity, and inflammatory bowel disease.
Their presence in the gut microbiota can serve as biomarkers for dietary habits and overall gut health, reflecting the balance between beneficial and potentially harmful microbial species.
Additionally, Alloprevotella species are found in the oral cavity and respiratory tract, where they can be associated with various health conditions.
Understanding the role of Alloprevotella in health and disease is essential for developing targeted therapeutic strategies and maintaining a balanced microbiome.
Alloprevotella belongs to the Bacteroidetes phylum and is part of the Prevotellaceae family. Alloprevotella species are Gram-negative, non-spore-forming, and rod-shaped bacteria. [10.]
The name Alloprevotella comes from the Greek "allos" meaning "different," indicating that it is different from but related to Prevotella.
Alloprevotella was proposed as a new genus in 2013 to accommodate two species: [2.]
They are obligate anaerobes, meaning they thrive in environments devoid of oxygen. [10.]
They produce acetic and succinic acids as fermentation end products. [2.]
Depending on the context, Alloprevotella may have health benefits and/or health risks for human health.
Alloprevotella are known to be a normal part of the human microbiome, colonizing the digestive tract including the oral cavity. It helps maintain microbial stability. [8.]
Alloprevotella are commonly associated with plant-rich diets abundant in carbohydrates and fibers. This genus is often prevalent in agrarian societies with diets high in polysaccharides and fibers, as opposed to Western diets that are high in fats and proteins. [6.]
One study introducing a short-term dietary fiber intervention significantly increased the growth of Alloprevotella. This indicates that dietary fiber can enhance the abundance of this genus in the gut microbiota. [8.]
The increase in Alloprevotella abundance after dietary fiber intake suggests that it has a beneficial role in gut health. [8.]
However, research is not all clear-cut on Alloprevotella.
While some strains are associated with beneficial effects such as improved cardiovascular health and better glucose metabolism, others may have pathobiontic properties contributing to inflammatory diseases like metabolic syndrome, obesity, inflammatory bowel disease, and rheumatoid arthritis. [6.]
The presence and levels of Alloprevotella in the gut microbiota could serve as potential biomarkers for dietary habits and overall gut health, reflecting the balance between beneficial and potentially harmful microbial species. [6.]
These bacteria are commonly found in the human oral cavity and are associated with oral dysbiotic infections, such as dental caries and periodontitis. [10.]
A. rava has been found in higher proportions in individuals with halitosis, dental caries, and periodontitis, but decreased in conditions like Behçet's disease.
There is emerging evidence linking A. rava to oral carcinogenesis, although its pathogenic features are not yet fully understood. [10.]
Alloprevotella and Prevotella species are often found together, and co-implicated in oral and respiratory tract infections. [7.]
Prevotella and Alloprevotella species are also implicated in various digestive conditions including gastroesophageal reflux disease, gastritis, inflammatory bowel disease, and different types of cancers in the gastrointestinal tract. [3.]
In the respiratory tract, these bacteria are part of the core microbiota and are associated with conditions like chronic obstructive pulmonary disease (COPD) and cystic fibrosis. [3.]
Interestingly, low levels of Alloprevotella were associated with low blood pressure, although the opposite, that high levels of Alloprevotella were associated with high blood pressure, was not explicitly stated. [9.]
Alloprevotella levels are assessed in stool samples. Stool samples may be collected from the comfort of home.
Occasionally, Alloprevotella testing may be done from vaginal samples, samples from oral abscesses or the oral cavity, or from sputum samples to assess for pathogenic overgrowth of this bacterium in these areas.
Testing may require avoidance of certain medications and/or supplements including probiotics prior to sample collection. It is important to consult with the ordering provider for full test preparation instructions.
Optimal levels are generally determined by assessing the balance of healthy vs. unhealthy microbiota. It is important to consult with the laboratory company used for test interpretation.
Overall, a moderate amount of Alloprevotella as part of a healthy microbiome is likely ideal for health.
Results should be interpreted within the context of an individual’s health history. Elevated Alloprevotella in a bodily fluid or tissue sample may indicate an active infection and a need for treatment, especially in a symptomatic individual.
Low levels of an individual strain should be interpreted within the context of an individual’s comprehensive microbiome assessment as well as her or his symptom picture.
Rebalancing the microbiome may consist of therapies including natural microbials or antibiotics, probiotics, gut healing protocols, as well as the use of food-based sources of prebiotic fiber to naturally promote the growth of bacteria such as Alloprevotella. [8.]
In addition to Alloprevotella, other members of the gut microbiome and associated metabolites have been studied as potential biomarkers for various health conditions.
Several other bacterial genera within the gut microbiome have been investigated as potential biomarkers including Bacteroides, Prevotella, Faecalibacterium, and Akkermansia.
Changes in the abundance and composition of these bacteria have been linked to conditions such as inflammatory bowel diseases, obesity, and metabolic disorders. [1.]
Alloprevotella is a genus of bacteria that belongs to the Bacteroidetes phylum. These bacteria are commonly found in the human oral cavity and the gastrointestinal tract, playing a role in the complex ecosystem of the microbiota.
Alloprevotella contributes to maintaining a balanced microbiota by participating in the breakdown of complex carbohydrates and fibers, producing short-chain fatty acids (SCFAs) such as acetate and propionate, and interacting with other microbial species to support a healthy gut environment.
Research on Alloprevotella is ongoing, but it has been associated with both positive and negative health effects:
Currently, Alloprevotella is not used as a probiotic. Probiotics are typically selected for their well-established benefits and safety profiles, and more research is needed to determine whether Alloprevotella could be beneficial and safe for such use.
To support a healthy microbiota, consider the following:
Alloprevotella interacts with other gut bacteria to maintain a balanced microbiota. These interactions can influence the overall composition and function of the gut microbiome, impacting the host's health. However, specific interactions and their implications are still being studied.
For more information about Alloprevotella and microbiota health, consider consulting:
Click here to compare testing options and order testing for Alloprevotella.
[1.] Caso, J.R., MacDowell, K.S., González-Pinto, A. et al. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder. Transl Psychiatry 11, 645 (2021). https://doi.org/10.1038/s41398-021-01755-3
[2.] Downes J, Dewhirst FE, Tanner ACR, Wade WG. Description of Alloprevotella rava gen. nov., sp. nov., isolated from the human oral cavity, and reclassification of Prevotella tannerae Moore et al. 1994 as Alloprevotella tannerae gen. nov., comb. nov. Int J Syst Evol Microbiol. 2013 Apr;63(Pt 4):1214-1218. doi: 10.1099/ijs.0.041376-0. Epub 2012 Jun 29. PMID: 22753527; PMCID: PMC3709537.
[3.] Könönen E, Gursoy UK. Oral Prevotella Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts. Front Microbiol. 2022 Jan 6;12:798763. doi: 10.3389/fmicb.2021.798763. PMID: 35069501; PMCID: PMC8770924.
[4.] Morgan DM, Cao Y, Miller K, et al. Microscopic Colitis Is Characterized by Intestinal Dysbiosis. Clinical Gastroenterology and Hepatology. 2020;18(4):984-986. doi:https://doi.org/10.1016/j.cgh.2019.06.035
[5.] Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Frontiers in Immunology. 2020;11. doi:https://doi.org/10.3389/fimmu.2020.00906
[6.] Precup G, Vodnar D-C. Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. British Journal of Nutrition. 2019;122(2):131-140. doi:10.1017/S0007114519000680
[7.] Tett A, Pasolli E, Masetti G, Ercolini D, Segata N. Prevotella diversity, niches and interactions with the human host. https://iris.unitn.it/
[8.] Tian T, Zhang X, Luo T, Wang D, Sun Y, Dai J. Effects of Short-Term Dietary Fiber Intervention on Gut Microbiota in Young Healthy People. Diabetes Metab Syndr Obes. 2021 Aug 5;14:3507-3516. doi: 10.2147/DMSO.S313385. PMID: 34385825; PMCID: PMC8353528.
[9.] Two Probiotics Identified as Promising Hypertension Treatments. ASM.org. Accessed June 26, 2024. https://asm.org/press-releases/2023/october/two-probiotics-identified-as-promising-hypertensio
[10.] Ulger Toprak N, Duman N, Sacak B, Ozkan MC, Sayın E, Mulazimoglu L, Soyletir G. Alloprevotella rava isolated from a mixed infection of an elderly patient with chronic mandibular osteomyelitis mimicking oral squamous cell carcinoma. New Microbes New Infect. 2021 Apr 14;42:100880. doi: 10.1016/j.nmni.2021.100880. PMID: 34136264; PMCID: PMC8176353.